Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 115 (RPL21P115)

Target: RPL21P115
Molecular classification: Other (Pseudogene)

Overview

RPL21P115 (ribosomal protein L21 pseudogene 115) is a processed genomic pseudogene without known protein-coding function or physiological activity. The corresponding gene (RPL21) encodes a component of the 60S ribosomal subunit—a protein essential for ribosome structure and cellular protein synthesis—but the pseudogene itself does not produce functional protein and has not been associated with any biological mechanisms, diseases, or therapeutic strategies.

Other names: RPL21_54_1451

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 115 (RPL21P115).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 115 (RPL21P115).

Explore the full profile